๐Ÿซ€ Pulmonary Embolism in the ICU

ESC 2019 PESI / sPESI ISCCM
Obstructive shock RV failure Thrombolysis Led by Irwin & Rippe ยท with Marino & Oh's ยท ESC 2019 PE guideline
๐Ÿ“… Last reviewed July 2026 ยท Next review January 2027 ยท Compiled by Dr. Anmol Srivastava Anaesthesia, Emergency Medicine & Critical Care Medicine ยท Reviewed by Dr. Tanya Chawla Anaesthesia & Critical Care
๐Ÿซ€ 1 ยท Overview

Pulmonary embolism

"PE kills through acute right-ventricular failure: a clot obstructs the pulmonary circulation, RV afterload rises abruptly, and a thin-walled RV dilates and fails. Everything โ€” the risk score, the imaging, the decision to lyse โ€” is a way of asking one question: is the right ventricle coping?"

Summarised from Irwin & Rippe's Intensive Care Medicine; with Marino's The ICU Book, Oh's Intensive Care Manual and ESC.

PE is the pulmonary end of venous thromboembolism (VTE) (with DVT). Most ICU patients are at high VTE risk; more than half of fatal PEs were never suspected โ€” so the diagnosis is the hard part.

๐ŸŽฏ 2 ยท Risk Factors (Virchow)

Who clots

StasisEndothelial injuryHypercoagulability
Immobility, ICU staySurgery, traumaMalignancy
Long travel, paresisCentral venous cathetersPregnancy/puerperium, oestrogens
Heart failurePrior DVTSepsis, inherited thrombophilia, antiphospholipid

Thrombophilia is present in up to half of young/idiopathic VTE, but screening rarely changes acute management โ€” treat the clot, defer thrombophilia work-up.

๐Ÿšฆ 3 ยท Risk Stratification (ESC)

Is the RV coping? โ€” this decides treatment

CategoryHaemodynamicsRV dysfunction (imaging)Troponin
High-risk (massive)Shock / persistent hypotension / arrestYesUsually +
Intermediate-highStableYes+
Intermediate-lowStableOne or neither of RV dysfunction / troponinยฑ
Low-riskStableNo (sPESI 0)โˆ’
Definitions you must know
  • Haemodynamic instability = cardiac arrest, obstructive shock (SBP <90 or vasopressors + hypoperfusion), or persistent hypotension (SBP <90 or a drop โ‰ฅ40 mmHg for >15 min).
  • sPESI (each 1 point): age >80, cancer, chronic cardiopulmonary disease, HR โ‰ฅ110, SBP <100, SpOโ‚‚ <90%. Score 0 = low risk.
๐Ÿฉบ 4 ยท Diagnosis

Confirm it โ€” pathway depends on stability

A

Unstable (suspected high-risk)

Don't wait for CT โ€” bedside echo: RV dilatation/strain supports the diagnosis and justifies reperfusion. CTPA as soon as safe.

B

Stable

Wells / Geneva pre-test probability โ†’ if unlikely, D-dimer (age-adjusted) to rule out; if likely or D-dimer positive โ†’ CTPA (V/Q if contrast contraindicated).

C

Supporting tests

ECG (sinus tachy, S1Q3T3, RV strain), ABG (hypoxaemia, โ†‘ Aโ€“a), troponin/BNP (RV strain), leg compression ultrasound (DVT).

๐Ÿ’‰ 5 ยท Management by Category

Treat to the risk

CategoryTreatment
High-risk (shock)Systemic thrombolysis (e.g. alteplase) unless contraindicated; if contraindicated/failed โ†’ catheter-directed therapy or surgical embolectomy. Support: cautious fluids, noradrenaline ยฑ inotrope, Oโ‚‚; ECMO as a bridge in extremis.
Intermediate-highAnticoagulate + monitor closely; rescue thrombolysis (or catheter therapy) if they deteriorate. Not routine full-dose lysis.
Intermediate-lowAnticoagulation; admit/observe.
Low-riskAnticoagulation; consider early discharge/outpatient (Hestia/sPESI 0).
โš ๏ธ The RV-failure trap at intubation

Positive-pressure ventilation and induction agents can collapse a failing RV. Avoid intubation if possible; if unavoidable, optimise preload/pressor first, use gentle settings, and avoid fluid overload (a distended RV worsens by bowing the septum).

๐Ÿ’Š 6 ยท Anticoagulation

The backbone of every category

AgentUseNote
DOAC (apixaban, rivaroxaban)First line for mostSingle-drug; edoxaban/dabigatran need LMWH lead-in
LMWHCancer, pregnancy, initial therapyRenally cleared; weight-based
UFH infusionHigh-risk/unstable, severe renal failure, planned lysisTitratable, rapidly reversible
WarfarinAntiphospholipid syndrome, valvesOverlap with heparin until INR therapeutic

Duration: provoked by a transient factor โ†’ ~3 months; unprovoked, recurrent or ongoing risk (cancer, thrombophilia) โ†’ extended/indefinite, reassessing bleeding risk.

๐Ÿงฉ 7 ยท Special Situations

Adjuncts & caveats

  • IVC filter: only when anticoagulation is contraindicated or PE recurs despite adequate anticoagulation โ€” not routine.
  • Cancer-associated VTE: DOAC or LMWH; watch GI/GU bleeding with DOACs.
  • Pregnancy: LMWH (avoid DOAC/warfarin); tailored diagnostic pathway.
  • Prophylaxis: almost all ICU patients need pharmacological or mechanical VTE prophylaxis โ€” prevention beats treatment.
๐Ÿšซ 8 ยท Common Mistakes

Common mistakes

โŒ 1 โ€” Large fluid boluses in RV failure

Over-filling a strained RV worsens septal bowing and cardiac output. Give small, cautious challenges and start noradrenaline early.

โŒ 2 โ€” Waiting for CT in the crashing patient

Use bedside echo โ€” RV strain justifies reperfusion when CT isn't safe.

โŒ 3 โ€” Routine lysis of all intermediate-risk PE

Full-dose lysis in stable intermediate-high PE increases bleeding โ€” anticoagulate and watch, lyse only if they deteriorate.

โŒ 4 โ€” D-dimer in high pre-test probability

A negative D-dimer does not exclude PE when probability is high โ€” go to imaging.

โŒ 5 โ€” Forgetting prophylaxis

Most fatal PEs are unsuspected โ€” VTE prophylaxis for nearly every ICU patient.

๐ŸŽ“ 9 ยท Exam Pearls โ€” DrNB / IDCCM / IFCCM

Exam pearls

Q: Define high-risk PE.
PE with haemodynamic instability โ€” cardiac arrest, obstructive shock, or persistent hypotension โ€” regardless of the imaging.

Q: Intermediate-high vs intermediate-low?
Both stable; intermediate-high has both RV dysfunction on imaging and raised troponin.

Q: When do you thrombolyse?
High-risk PE (shock) unless contraindicated; as rescue in intermediate-high PE that deteriorates.

Q: First-line anticoagulant?
A DOAC for most; UFH infusion if unstable/renal failure/planned lysis; LMWH in cancer/pregnancy.

Q: When is an IVC filter indicated?
Anticoagulation contraindicated, or recurrent PE despite adequate anticoagulation.

โญ 10 ยท Key Differences

All the comparisons in one place

The distinctions that decide reperfusion and answers โ€” gathered at the end.

High vs Intermediate vs Low-risk PE

FeatureHigh-riskIntermediateLow-risk
HaemodynamicsUnstable / shockStableStable
RV dysfunctionYesยฑNo
TreatmentThrombolysis / embolectomyAnticoagulate ยฑ rescue lysisAnticoagulate ยฑ early discharge

Thrombolysis vs Anticoagulation

FeatureThrombolysisAnticoagulation
ActionActively dissolves clotPrevents propagation; body lyses over time
SpeedRapid RV unloadingGradual
Main riskMajor/intracranial bleedingBleeding (lower)
IndicationHigh-risk (shock); rescueAll PE โ€” the backbone

CTPA vs V/Q scan

FeatureCTPAV/Q scan
Availability/speedFast, first-lineSlower, limited hours
Best whenMost patientsContrast allergy, renal failure, pregnancy (low radiation to breast), normal CXR
ExtrasAlternative diagnoses, RV sizeNo alternative diagnosis
๐Ÿ“š 11 ยท References

References

  1. Irwin RS, Lilly CM, Mayo PH, Rippe JM (eds). Irwin & Rippe's Intensive Care Medicine. 9th ed. Wolters Kluwer; 2023.
  2. Marino PL. Marino's The ICU Book. 5th ed. Wolters Kluwer; 2025.
  3. Bersten AD, Handy JM (eds). Oh's Intensive Care Manual. Elsevier; 2026.
  4. Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2020;41:543โ€“603.
  5. Meyer G, Vicaut E, Danays T, et al. (PEITHO). Fibrinolysis for intermediate-risk pulmonary embolism. N Engl J Med. 2014;370:1402โ€“1411.
  6. Stevens SM, Woller SC, Kreuziger LB, et al. Antithrombotic therapy for VTE disease: CHEST guideline. Chest. 2021;160:e545โ€“e608.